Apellis Pharmaceuticals, Inc. Common Stock (APLS) is a publicly traded Healthcare sector company. As of May 20, 2026, APLS trades at $41.03 with a market cap of $5.25B and a P/E ratio of -25.64. APLS moved -0.04% today. Year to date, APLS is +64.32%; over the trailing twelve months it is +137.44%. Its 52-week range spans $16.10 to $41.14. Analyst consensus is neutral with an average price target of $39.50. Rallies surfaces APLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Apellis Pharmaceuticals, Inc. Common Stock (APLS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. APLS moved -0.04% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $41.03 |
| Market Cap | $5.25B |
| P/E Ratio | -25.64 |
| EPS | $-1.60 |
| Dividend Yield | 0.00% |
| 52-Week High | $41.14 |
| 52-Week Low | $16.10 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $781.37M |
| Net Income | $-197.88M |
| Gross Margin | 0.00% |
18 analysts cover APLS: 0 strong buy, 2 buy, 16 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $39.50.